Your browser doesn't support javascript.
SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage.
Sui, Yongjun; Li, Jianping; Venzon, David J; Berzofsky, Jay A.
  • Sui Y; Vaccine Branch, Center of Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
  • Li J; Vaccine Branch, Center of Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
  • Venzon DJ; Biostatistics and Data Management Section, Center of Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
  • Berzofsky JA; Vaccine Branch, Center of Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
Front Immunol ; 12: 658428, 2021.
Article in English | MEDLINE | ID: covidwho-1389178
ABSTRACT
SARS-CoV-2 virus causes upper and lower respiratory diseases including pneumonia, and in some cases, leads to lethal pulmonary failure. Angiotensin converting enzyme-2 (ACE2), the receptor for cellular entry of SARS-CoV-2 virus, has been shown to protect against severe acute lung failure. Here, we provide evidence that SARS-CoV-2 spike protein S1 reduced the mRNA expression of ACE2 and type I interferons in primary cells of lung bronchoalveolar lavage (BAL) from naïve rhesus macaques. The expression levels of ACE2 and type I interferons were also found to be correlated with each other, consistent with the recent finding that ACE2 is an interferon-inducible gene. Furthermore, induction of ACE2 and type I interferons by poly IC, an interferon inducer, was suppressed by S1 protein in primary cells of BAL. These observations suggest that the downregulation of ACE2 and type I interferons induced by S1 protein may directly contribute to SARS-CoV-2-associated lung diseases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Animals Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: FIMMU.2021.658428

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / Spike Glycoprotein, Coronavirus / Angiotensin-Converting Enzyme 2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Animals Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: FIMMU.2021.658428